Ningxia Zhongke Biotechnology Co (SHSE:600165) Institutional Ownership: 0.12% (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600165 Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
52 GF Score
Price ¥3.14
GF Value ¥2.35
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ningxia Zhongke Biotechnology Co Institutional Ownership?

Ningxia Zhongke Biotechnology Co SHSE:600165 -1.26% 52 Institutional Ownership is 0.12% as of Sep. 05, 2026. GuruFocus rates SHSE:600165 with a GF Score™ of 52/100 and a GF Value™ of ¥2.35 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ningxia Zhongke Biotechnology Co's institutional ownership is 0.12%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ningxia Zhongke Biotechnology Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ningxia Zhongke Biotechnology Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Ningxia Zhongke Biotechnology Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Ningxia Zhongke Biotechnology Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ningxia Zhongke Biotechnology Co Institutional Ownership Chart

Ningxia Zhongke Biotechnology Co Historical Data

The historical data trend for Ningxia Zhongke Biotechnology Co can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.04 0.04 0.15 0.15 0.15 0.12 0.12 0.12 0.12 0.12
SHSE:600165
52GF Score
Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ningxia Zhongke Biotechnology Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.12% mean?
Ningxia Zhongke Biotechnology Co (SHSE:600165) has a Institutional Ownership of 0.12% as of Sep. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ningxia Zhongke Biotechnology Co and its competitors.
Is Ningxia Zhongke Biotechnology Co's Institutional Ownership too high?
Ningxia Zhongke Biotechnology Co's current Institutional Ownership is 0.12%. Overall, Ningxia Zhongke Biotechnology Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ningxia Zhongke Biotechnology Co's Institutional Ownership compare to LIN and SHW?
Ningxia Zhongke Biotechnology Co's Institutional Ownership of 0.12% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Chemicals company?
A good Institutional Ownership depends on the Chemicals industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ningxia Zhongke Biotechnology Co and its competitors. Ningxia Zhongke Biotechnology Co's current Institutional Ownership is 0.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningxia Zhongke Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co (SHSE:600165) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.35, compared to a current price of ¥3.14 — trading 33.6% above its estimated fair value. The current Institutional Ownership is 0.12%. Ningxia Zhongke Biotechnology Co's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Ningxia Zhongke Biotechnology Co (SHSE:600165), the current Institutional Ownership is 0.12% as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ningxia Zhongke Biotechnology Co (SHSE:600165) Overvalued in 2026?

Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co stock appears to be overvalued. The current stock price of ¥3.14 is trading 33.6% above its estimated GF Value™ of ¥2.35. GuruFocus considers Ningxia Zhongke Biotechnology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600165:

  • Institutional Ownership: 0.12%
  • GF Value™: ¥2.35 vs. price of ¥3.14 (33.6% above fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600165 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ningxia Zhongke Biotechnology Co Business Description

Address Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
52GF Score

Get the complete analysis for SHSE:600165

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.14
Price
¥2.35
GF Value